I dedidcated my research activity to Gynecologic oncology with a particular focus on molecular biology and characterization of ovarian cancer
EDUCATION
Catholic University of the Sacred Heart
160
Scopus Publications
Scopus Publications
The Hugo™ RAS system in gynecologic robotic surgery: a systematic review of current applications Chiara Innocenzi, Massimo Criscione, Matteo Pavone, Nicolò Bizzarri, Andrea Rosati, Marco Petrillo, Riccardo Oliva, Denis Querleu, Anna Fagotti, Lise Lecointre, Mariano Giménez, Barbara Seeliger, Antonello Forgione, Francesco Fanfani, Jacques Marescaux Journal of Robotic Surgery, 2026 Introduction The Hugo™ Robotic-Assisted Surgery (RAS) system is a recent development in minimally invasive gynecologic surgery. Following regulatory approval, its clinical use has expanded. However, comprehensive evidence on feasibility, safety and surgical outcomes has not been established. This systematic review synthesizes the available clinical data on the application of this robotic system across gynecologic procedures. Materials and methods A systematic review was conducted in accordance with PRISMA guidelines and registered in PROSPERO (CRD42024519329), interrogating PubMed, Web of Science and Embase databases. Manuscripts reporting data on patients undergoing gynecologic surgical procedures with the Hugo™ RAS platform were included in the analysis. Results Qualitative analysis was conducted on twelve studies including 445 patients. Hysterectomy was the main procedure (either total or supracervical; n = 289, 64.9%), with primary indications including fibromatosis ( n = 149, 33.5%) and endometriosis ( n = 92, 20.7%). Some studies ( n = 5, 41.7%) included patients with gynecologic malignancies, mainly endometrial cancer; one reported robotic management of a perivesical recurrence. Few conversions (laparotomy n = 1, 0.22%; laparoscopy n = 5, 1.12%), intraoperative complications ( n = 4, 0.90%), and postoperative complications (Clavien-Dindo grade ≥ II, 1.57%) occurred. Weighted mean operative, console and docking times were 141.84 ± 28.73, 97.98 ± 28.13, and 5.90 ± 0.94 min, respectively. Estimated blood loss averaged 110.75 ± 84.16 mL, and mean hospital stay was 2 ± 1 days. Reported system malfunctions were generally manageable without significant clinical consequences. Conclusions Current evidence indicates that the system can be safely implemented by gynecologic surgeons in routine clinical practice. Nevertheless, further high-quality research is required to determine long-term outcomes and to assess its integration within the evolving landscape of digital surgical technologies.
Accuracy and clinical impact of MRI in early-stage cervical cancer after cervical conization, a retrospective study M. Dolciami, M. Criscione, N. Bizzarri, A. Amerighi, A. Napoletano, L. Russo, G. Scaglione, D. Giannarelli, M. Petrillo, E. Sala, F. Fanfani, B. Gui European Radiology, 2026 Objective To assess the accuracy of MRI in detecting residual disease after conization in patients with early-stage cervical cancer (CC) and to evaluate the impact of MRI on FIGO staging and surgical management. Materials and methods Between January 2018 and December 2023, a consecutive series of patients with early-stage invasive CC undergoing conization, pre-operative pelvic MRI, and surgery were included in this retrospective study. Two experienced radiologists reviewed the MRI scans for the presence of residual tumor, assessed on T2-weighted, diffusion-weighted, and contrast-enhanced sequences, if available. MRI findings were compared with surgical pathology to evaluate diagnostic performance and clinical impact. Results A total of 108 patients were included in the study. MRI detected residual disease with an accuracy of 78.7% (95% CI 71.0–86.4), sensitivity of 66%, specificity of 90.9%, positive predictive value of 87.5%, and negative predictive value of 73.5%. The use of contrast agent showed no significant difference in overall accuracy, with an accuracy of 74.5% for contrast-enhanced MRI (CE-MRI) and 83% for non-CE-MRI ( p = 0.28), respectively. MRI correctly staged 73.8% of cases, suggested the correct extent of radicality in 79.7% of cases following the 2018 ESGO guidelines, and the appropriate type of hysterectomy (simple vs. radical) in 90.9% of cases following the SHAPE study. Conclusion Non-CE MRI is a reliable and sufficient tool for detecting residual tumor after conization in early-stage CC, as contrast administration offers no additional diagnostic value. Accurate pre-operative identification of residual disease may refine FIGO staging and assist in tailoring surgical strategies. Key Points Question MRI evaluation of residual tumor after cervical conization in early-stage cervical cancer is critical to optimize surgical planning noninvasively and avoid overtreatment. Findings MRI correctly identified residual disease with high specificity (90.9%) and moderate sensitivity (66%); contrast enhancement did not significantly improve diagnostic accuracy. Clinical relevance MRI, particularly non-contrast protocols, reliably excludes post-conization residual disease and aids in selecting appropriate surgical treatment, reducing overtreatment in early-stage cervical cancer. Graphical Abstract
Natural language processing as consultation service platform or clinical decision support system in gynecologic oncology: a systematic review Andrea Rosati, Massimo Criscione, Livia Lilli, Marco Petrillo, Giampiero Capobianco, Stefano Patarnello, Anna Fagotti International Journal of Gynecological Cancer, 2026 OBJECTIVE: Natural language processing is emerging as a key application of artificial intelligence in oncology. This systematic review aims to evaluate the performance and methodological frameworks of natural language processing systems in gynecologic oncology. METHODS: We conducted a systematic review following the Preferred Reporting Items for Systematic Reviews and Meta-Analysis 2020 guidelines. MEDLINE, EMBASE, and Web of Science were searched for studies published between January 2015 and February 2025. Outcomes were synthesized across 3 research questions: the accuracy of natural language processing systems used as consultation service platforms; the accuracy of natural language processing systems used as clinical decision support systems; and the benchmarking methodologies applied, including their associated methodological outcomes. Consultation service platforms deliver general medical information, whereas clinical decision support systems provide recommendations that are integrated into the patient's clinical workflow. RESULTS: This review analyzed 12 retrospective studies. Consultation service platforms were less accurate than clinicians (60% vs 86.7%) and rated lower in response quality (2.96/5 vs 4.2/5) but outperformed guideline-based answers (1.54/2 vs 1.38/2). In cervical cancer, ChatGPT surpassed experts (7.0 vs 6.1). ChatGPT-4 showed a concordance of 70% with the National Comprehensive Cancer Network and 60% with the European Society of Gynaecological Oncology guidelines in clinical decision support tasks, with an overall recommendation accuracy of 75%. IBM Watson achieved a 72.8% concordance with guidelines. Prompting was applied from 100% to 37.5% across studies. Qualitative benchmarking varied across studies: 83.3% used clinical guidelines and 37.5% of consultation service platforms studies used expert answers. Four- or 5-point scales and binary scoring were used to assess consultation service platforms and clinical decision support systems, respectively. CONCLUSIONS: Clinicians remain superior in complex reasoning, but natural language processing systems demonstrate robust performance in guideline-driven tasks, with advantages in speed, readability, and reproducibility. However, performance declined in nuanced scenarios and among under-represented patient sub-groups. Large language models currently play a supportive rather than substitutive role in gynecologic oncology.
Expectant management or conization for persistent low-grade cervical intraepithelial neoplasia: Analysis of 5-year outcomes Giorgio Bogani, Francesco Sopracordevole, Giovanni Corso, Enrico Vizza, Paolo Scollo, Andrea Giannini, Violante Di Donato, Andrea Ciavattini, Rosa De Vincenzo, Barbara Gardella, Flavia Sorbi, Massimiliano Fambrini, Fabio Ghezzi, Jvan Casarin, Marco Petrillo, Caterina Borso, Noemi Tonti, Valentina Chiappa, Francesco Raspagliesi, Giuseppe Vizzielli Tumori, 2026 Objective: To investigate to describe outcomes of conization or expectant management for women with persistent (>24 months) low-grade cervical intra-epithelial neoplasia. Methods: This is a retrospective analysis focusing on five-year outcomes after persistent, histologically confirmed, low-grade cervical intra-epithelial neoplasia undergoing conization or expectant management. Results: Charts of 219 women with persistent low-grade cervical lesions were retrieved. Overall, 98 (44.7%) and 121 (55.3%) women had conization and observation, respectively. Patients receiving conization were older than patients having observation (43 (range, 24-77) vs. 39 (range, 25-68) years; p=0.013). Focusing on the group of patients receiving conization, 16 (16.3%) women were diagnosed with CIN2+. The five-year risk of secondary conization was 5% (n=5). Focusing on patients having observation (n=121), 18 (14.8%) patients received conization, after a median of 16.5 (range, 6-30) months. Seven (5.8%) and 11 (9.1%) patients were diagnosed with persistent CIN1 and CIN2+, respectively. Not fully visible squamous-columnar junction at colposcopic examination (p=0.035) was associated with CIN2+ occurrence. No invasive cancer was observed Conclusions: Conization for persistent low-grade cervical intra-epithelial neoplasia revealed “occult” CIN2+ in 16% of patients. However, expectant management appears safe and effective in this context, in women with fully visible squamous columnar junction. The decision between conization and expectant management should be discussed on an individual basis.
Tubal Stump Ectopic Pregnancy After IVF-ET in Patients Who Underwent Salpingectomy or Adnexectomy: A Qualitative Systematic Review Massimo Criscione, Giorgio Maria Baldini, Elisa Sanna, Laura Saderi, Giovanni Sotgiu, Mario Palumbo, Marco Petrillo, Giampiero Capobianco Medicina Lithuania, 2026 Background and Objectives: Ectopic pregnancy (EP) is a life-threatening medical and surgical condition. Tubal stump EPs and heterotopic pregnancies can occur after in vitro fertilization-embryo transfer (IVF-ET), even after salpingectomy. The purpose of this study is to investigate the risk factors, diagnosis, and treatment of tubal stump EPs after IVF-ET in patients with prior salpingectomy or adnexectomy. We also aim to evaluate the intrauterine pregnancy (IUP) outcome in cases of heterotopic pregnancy in this population. Materials and Methods: This systematic review (PROSPERO CRD42023352959) followed PRISMA guidelines. A literature search of MEDLINE®, Scopus, Web of Science, and clinicaltrials.gov was conducted on 30 April 2024. We included studies on tubal stump EP after IVF-ET in patients with previous salpingectomy or adnexectomy and created a qualitative summary. Results: We included 40 studies reporting on 57 patients (58 EP episodes). Most patients (69.0%) had prior bilateral salpingectomy. Tubal rupture occurred in 69.6% of cases, with 69.0% of these cases reporting hemoperitoneum. Abdominal pain was the most frequent symptom (71.7%). Heterotopic pregnancy occurred in 60.0% of cases (82.7% singletons). The IUP outcome was delivery in 81.9% of cases, with 95.5% of singletons delivering at term, compared with 40.0% of twins. The surgical approach (laparoscopy vs. laparotomy) did not change the IUP outcome. Tubal stump excision (74.1%) was the most common treatment. Overall, the certainty of the evidence was judged as moderate to very low according to the GRADE-CERQual approach, mainly due to small sample sizes, observational designs, and heterogeneity among studies. Conclusions: This review, the first on this topic, provides key data for counselling patients with a tubal stump heterotopic pregnancy. Despite its rarity, close follow-up until 8–10 weeks is recommended for IVF-ET patients with positive β-hCG, monitoring for abdominal pain. Successful management (expectant, medical, or surgical) should be guided by β-hCG levels and ultrasound findings (e.g., absence of heartbeat). Medical treatment shows encouraging obstetric outcomes and warrants further research.
Late Cervical Recurrence of Invasive Lobular Carcinoma Ten Years After Primary Breast Cancer: A Case Report and Review of the Literature Giulia Pellecchia, Stefano Restaino, Matteo Alfarè Lovo, Martina Arcieri, Monica Della Martina, Marco Petrillo, Giampiero Capobianco, Lorenza Driul, Giuseppe Vizzielli, and Healthcare Switzerland, 2026 Invasive lobular carcinoma (ILC) accounts for approximately 15% of breast cancers and the most common neoplasm in the female population. Cervical involvement is exceptionally rare and often underrecognized. This relationship is well-defined in the context of breast and ovarian cancer syndrome related to BRCA gene mutations. However, it is also observed in rare but underreported cases of cervical metastases originating from breast cancer. The objective of this manuscript is to describe a rare case of cervical recurrence of invasive lobular carcinoma and summarize comparable case to guide future gynecologic follow-up strategies. Therefore, we report the case of a 60-year-old woman who developed a late cervical recurrence of ILC ten years after her initial breast cancer diagnosis. The patient had previously undergone mastectomy for ER-positive, PR-positive, HER2-negative ILC, followed by five years of adjuvant endocrine therapy. She remained disease-free until presenting with post-menopausal bleeding, urinary symptoms, and acute renal failure. Pelvic examination and ultrasonography revealed an enlarged, indurated cervix with bilateral hydroureteronephrosis. Biopsy demonstrated a discohesive infiltrate consistent with metastatic lobular carcinoma, confirmed by immunohistochemistry (GATA3+, CK7+, ER/PR+, E-cadherin−, CK20−, CDX2−). Staging PET-CT showed additional metastases involving bone, peritoneum, and lymph nodes. The patient began systemic therapy with ribociclib plus letrozole, achieving radiologic improvement of the cervical lesion and abdominal disease. After a follow-up of several months, she maintains stable disease but has persistent chronic renal impairment secondary to obstructive uropathy. This case highlights the ability of ILC to recur after long latency and to metastasize to unusual gynecologic sites such as the cervix. We also review the literature on cervical recurrence from lobular carcinoma to emphasize the importance of gynecologic surveillance in breast cancer survivors and to identify areas that require further investigation.
Levonorgestrel-releasing intra-uterine device alone for managing early-stage endometrial cancer and endometrial hyperplasia with atypia in patients unfit for surgery: the ENDOIUD study Marco Petrillo, Matilde Degano, Martina Arcieri, Giorgio Bogani, Francesco Legge, Ursula Catena, Giuseppe Cucinella, Diego Raimondo, Vito Andrea Capozzi, Giorgia Dinoi, Eleonora La Fera, Simone Bruni, Lorenzo Ceppi, Alessandro Lucidi, Francesco D’Antonio, Emanuela D’Angelo, Francesco Dessole, Giuseppe Virdis, Paolo Casadio, Raffaella Iodice, Mariano Catello Di Donna, Roberto Berretta, Francesco Raspagliesi, Francesco Fanfani, Vito Chiantera, Renato Seracchioli, Lorenza Driul, Stefano Restaino, Giampiero Capobianco, Giuseppe Vizzielli International Journal of Gynecological Cancer, 2026
Management of Patients with Epithelial Ovarian Cancer: A Systematic Comparison of International Guidelines from Scientific Societies (AIOM-BGCS-ESGO-ESMO-JGSO-NCCN-NICE) Martina Arcieri, Veronica Tius, Sara Filippin, Giovanni Aletti, Domenica Lorusso, Anna Fagotti, Jalid Sehouli, Ignacio Zapardiel, Pierandrea De Iaco, Paolo Scollo, Andrea Ciavattini, Marco Petrillo, Violante Di Donato, Federica Perelli, Giorgio Bogani, Stefano Restaino, Giuseppe Vizzielli, and Cancers, 2025 Epithelial ovarian cancer (EOC) remains the most lethal gynecological malignancy worldwide, primarily due to late-stage diagnosis, limited early screening tools, and the aggressive nature of the disease. Increasing global efforts have been directed toward harmonizing clinical guidelines and ensuring equitable access to optimal care. This narrative review provides a comprehensive overview and critical comparison of the most recent international guidelines for ovarian cancer management, emphasizing similarities and discrepancies. Each section examines diagnostic, surgical, and therapeutic recommendations across all disease stages—from prevention to recurrence. Emerging advances that are reshaping the management of EOC such as preclinical models and the application of artificial intelligence are also discussed. This work provides an updated and practical synthesis to support clinicians, researchers, and policymakers in optimizing ovarian cancer management and guiding future research priorities in precision oncology.
Maternal first trimester SIMPLE nutritional score, early markers of placental function and pregnancy outcome: a prospective multicenter Italian study (SIMPLE study) Francesca Parisi, Chiara Coco, Giovanna Esposito, Stefano Guerriero, Valeria Savasi, Luca Marozio, Felice Petraglia, Arsenio Spinillo, Maurizio Guida, Giampiero Capobianco, Nicoletta Di Simone, Maddalena Morlando, Rosario D’anna, Luigi Nappi, Irene Cetin, , Giorgia Boni, Elisabetta Marelli, Giulia Marchitelli, Roberta Corneo, Eleonora Fumagalli, Michele Vignali, Marinella Dell’Avanzo, Lucia Pasquini, Giulia Masini, Sandro Gerli, Irene Giardina, Chiara Benedetto, Annalisa Tancredi, Fausta Benvenuti, Camilla Berlingheri, Pantaleo Greco, Marco Palumbo, Maria Giovanna Verzi, Tommaso Simoncini, Caterina Neri, Antonio Lanzone, Mariachiara Bosco, Carlotta Tosadori, Massimo Franchi, Ettore Cicinelli, Silvia Ajossa, Camilla Desogus, Stefano Angioni, Maurizio N. D’Alterio, Elena Silvestri, Marco Petrillo, Giuseppe Virdis, Andrea Ciavattini European Journal of Clinical Nutrition, 2025
Chemo-conization in Early-sTage cERvical caNcer >2 cm scheduled for fertilItY-sparing approach: an analysis of the ETERNITY project Giorgio Bogani, Giovanni Scambia, Mario Malzoni, Jvan Casarin, Giuseppe Vizzielli, Frédéric Amant, Francesco Raspagliesi, Giorgio Bogani, Giovanni Scambia, Anna Fagotti, Francesco Fanfani, Rosa De Vincenzo, Andrea Ciavattini, Francesco Sopracordevole, Nicolò Clemente, Anna Del Fabro, Monica Buttignol, Stefano Cianci, Giuseppe Sarpietro, Maria Grazia Matarazzo, Mario Malzoni, Francesca Falcone, Jvan Casarin, Fabio Ghezzi, Enrico Vizza, Roberto Berretta, Marco Petrillo, Giampiero Capobianco, Giovanna Scarfone, Filippo Casaccia, Mariasole Fichera, Livio Leo, Giulio Sozzi, Alessio Colalillo, Francesco Cosentino, Barbara Gardella, Renato Serrachioli, Diego Raimondo, Vito Chiantera, Alfredo Ercoli, Mattia Dominoni, Enrico Zupi, Gabriele Centini, Stefano Uccella, Massimo Franchi, Filippo Alberto Ferrari, Anna Myriam Perrone, Pierandrea De Iaco, Francesco Multinu, Vanna Zanagnolo, Gabriella Schivardi, Luigi Antonio De Vitis, Ilaria Cuccu, Federico Ferrari, Giuseppe Vizzielli, Stefano Restaino, Lorenza Driul, Martina Arcieri, Flavia Sorbi, Massimiliano Fambrini, Lorenzo Aguzzoli, Vincenzo Dario Mandato, Filippo Murina, Eugenio Solima, Michele Vignali, Paolo Vercellini, Marcello Ceccaroni, Violante Di Donato, Andrea Giannini, Ludovico Muzii, Valentina Chiappa, Simona Palladino, Roberto Tozzi, Frédéric Amant, Francesco Raspagliesi International Journal of Gynecological Cancer, 2025
Short- and long-term outcomes of vaginal, laparoscopic, and robotic-assisted surgery in “oldest old” endometrial cancer Giorgio Bogani, Francesco Raspagliesi, Mario Malzoni, Ilaria Cuccu, Giuseppe Vizzielli, Giovanni Scambia, Fabio Ghezzi, Jvan Casarin, Andrea Giannini, Violante Di Donato, Pierandrea De Iaco, Anna Myriam Perrone, Francesco Plotti, Roberto Angioli, Stefano Cianci, Stefano Restaino, Marco Petrillo, Francesco Multinu, Luigi De Vitis, Gabriella Schivardi, Valentina Chiappa, Simona Palladino, Tullio Golia D'Augè, Simone Bruni, Flavia Sorbi, Massimiliano Fambrini, Francesca Falcone, Roberto Berretta, Luiz Felipe Lessa Ortiz, Francesco Fanfani, Anna Fagotti European Journal of Surgical Oncology, 2025
Sentinel node mapping in high-intermediate and high-risk endometrial cancer: Analysis of 5-year oncologic outcomes Ilaria Cuccu, Francesco Raspagliesi, Mario Malzoni, Enrico Vizza, Andrea Papadia, Violante Di Donato, Andrea Giannini, Pierandrea De Iaco, Anna Myriam Perrone, Francesco Plotti, Roberto Angioli, Jvan Casarin, Fabio Ghezzi, Stefano Cianci, Giuseppe Vizzielli, Stefano Restaino, Marco Petrillo, Flavia Sorbi, Francesco Multinu, Gabriella Schivardi, Luigi Antonio De Vitis, Francesca Falcone, Luca Lalli, Roberto Berretta, Michael D. Mueller, Roberto Tozzi, Vito Chiantera, Pierluigi Benedetti Panici, Francesco Fanfani, Giovanni Scambia, Giorgio Bogani European Journal of Surgical Oncology, 2024
Characteristics and outcomes of surgically staged multiple classifier endometrial cancer Giorgio Bogani, Ilaria Betella, Francesco Multinu, Jvan Casarin, Fabio GhezzI, Flavia Sorbi, Giuseppe VizziellI, Marco Petrillo, Stefano Cianci, Roberto Berretta, Biagio PaolinI, Francesco FanfanI, Luigi De Vitis, Giovanni Scambia, Andrea Mariani, Nicoletta Colombo, Francesco Raspagliesi European Journal of Surgical Oncology, 2024
Surgical management of anastomotic leakage related to ovarian cancer surgery: a narrative review Stefano Restaino, Sofia Schierano, Martina Arcieri, Barbara Costantini, Alice Poli, Sara Pregnolato, Giovanni Terrosu, Sergio Calandra, Marco Petrillo, Giulia Pellecchia, Alessandro Lucidi, Marko Klarić, Lorenza Driul, Vito Chiantera, Alfredo Ercoli, Cristina Taliento, Francesco Fanfani, Anna Fagotti, Giovanni Scambia, Giuseppe Vizzielli Frontiers in Surgery, 2024
Ergonomics in the operating room and surgical training: a survey on the Italian scenario Stefano Restaino, Marco D’Indinosante, Federica Perelli, Martina Arcieri, Vittorio Cherchi, Marco Petrillo, Anna Franca Cavaliere, Stefano Cianci, Giulia Pellecchia, Roberto Luca Meniconi, Alessandro Coppola, Vito Chiantera, Giovanni Scambia, Lorenza Driul, Giuseppe Vizzielli, and Frontiers in Public Health, 2024
Hysterectomy alone vs. hysterectomy plus sentinel node mapping in endometrial cancer: Perioperative and long-term results from a propensity-score based study Giorgio Bogani, Violante Di Donato, Andrea Papadia, Alessandro Buda, Jvan Casarin, Francesco Multinu, Francesco Plotti, Maria Luisa Gasparri, Ciro Pinelli, Anna Myriam Perrone, Simone Ferrero, Flavia Sorbi, Fabio Landoni, Innocenza Palaia, Giorgia Perniola, Pierandrea De Iaco, Stefano Cianci, Salvatore Gueli Alletti, Marco Petrillo, Giuseppe Vizzielli, Francesco Fanfani, Roberto Angioli, Ludovico Muzii, Fabio Ghezzi, Enrico Vizza, Michael D. Mueller, Giovanni Scambia, Pierluigi Benedetti Panici, Francesco Raspagliesi European Journal of Surgical Oncology, 2023
Outcomes of High-Grade Cervical Dysplasia with Positive Margins and HPV Persistence after Cervical Conization Andrea Giannini, Violante Di Donato, Francesco Sopracordevole, Andrea Ciavattini, Alessandro Ghelardi, Enrico Vizza, Ottavia D’Oria, Tommaso Simoncini, Francesco Plotti, Jvan Casarin, Tullio Golia D’Augè, Ilaria Cuccu, Maurizio Serati, Ciro Pinelli, Alice Bergamini, Barbara Gardella, Andrea Dell’Acqua, Ermelinda Monti, Paolo Vercellini, Giovanni D’Ippolito, Lorenzo Aguzzoli, Vincenzo Dario Mandato, Luca Giannella, Cono Scaffa, Antonino Ditto, Francesca Falcone, Chiara Borghi, Mario Malzoni, Alessandra Di Giovanni, Maria Giovanna Salerno, Viola Liberale, Biagio Contino, Cristina Donfrancesco, Michele Desiato, Anna Myriam Perrone, Pierandrea De Iaco, Simone Ferrero, Giuseppe Sarpietro, Maria G. Matarazzo, Antonio Cianci, Stefano Cianci, Sara Bosio, Simona Ruisi, Lavinia Mosca, Raffaele Tinelli, Rosa De Vincenzo, Gian Franco Zannoni, Gabriella Ferrandina, Marco Petrillo, Giampiero Capobianco, Annunziata Carlea, Fulvio Zullo, Barbara Muschiato, Stefano Palomba, Stefano Greggi, Arsenio Spinillo, Fabio Ghezzi, Nicola Colacurci, Roberto Angioli, Pierluigi Benedetti Panici, Ludovico Muzii, Giovanni Scambia, Francesco Raspagliesi, Giorgio Bogani Vaccines, 2023
Management of Patients Diagnosed with Endometrial Cancer: Comparison of Guidelines Stefano Restaino, Chiara Paglietti, Martina Arcieri, Anna Biasioli, Monica Della Martina, Laura Mariuzzi, Claudia Andreetta, Francesca Titone, Giorgio Bogani, Diego Raimondo, Federica Perelli, Alessandro Buda, Marco Petrillo, Pantaleo Greco, Alfredo Ercoli, Francesco Fanfani, Giovanni Scambia, Lorenza Driul, Giuseppe Vizzielli, and Cancers, 2023
Practice patterns and 90-day treatment-related morbidity in early-stage cervical cancer Giorgio Bogani, Violante Di Donato, Giovanni Scambia, Fabio Landoni, Fabio Ghezzi, Ludovico Muzii, Pierluigi Benedetti Panici, Francesco Raspagliesi, Giorgio Bogani, Violante Di Donato, Giovanni Scambia, Fabio Ghezzi, Jvan Casarin, Fabio Landoni, Giampaolo Di Martino, Tommaso Grassi, Anna Myriam Perrone, Pierandrea De Iaco, Francesco Multinu, Roberto Berretta, Vito A. Capozzi, Errico Zupi, Gabriele Centini, Antonio Pellegrino, Silvia Corso, Guido Stevenazzi, Anna Chiara Boschi, Giuseppe Comerci, Pantaleo Greco, Gennaro Scutiero, Francesco Sopracordevole, Giorgio Giorda, Mariasole Fichera, Tommaso Simoncini, Marta Caretto, Enrico Sartori, Federico Ferrari, Antonio Cianci, Giuseppe Sarpietro, Maria Grazia Matarazzo, Pierluigi Giampaolino, Giuseppe Bifulco, Michele Morelli, Michele Di Dio, Annamaria Ferrero, Nicoletta Biglia, Fabio Barra, Simone Ferrero, Stefano Cianci, Vito Chiantera, Giulio Sozzi, Alfredo Ercoli, Sergio Schettini, Teresa Orlando, Francesco G. Cannone, Giuseppe Ettore, Andrea Puppo, Elena Olearo, Umberto Leone Roberti Maggiore, Valeria Artuso, Innocenza Palaia, Giorgia Perniola, Rossana Tripodi, Tullio Golia D'Augè, Ilaria Cuccu, Margherita Fischetti, Giusi Santangelo, Assunta Casorelli, Andrea Giannini, Ottavia D’Oria, Giuseppe Vizzielli, Stefano Restaino, Alice Bergamini, Luca Bocciolone, Francesco Plotti, Roberto Angioli, Giulia Mantovani, Marcello Ceccaroni, Chiara Cassini, Mattia Dominoni, Laura Giambanco, Silvia Amodeo, Livio Leo, Raphaël Thommaset, Diego Raimondo, Renato Seracchioli, Mario Malzoni, Francesca Falcone, Franco Gorlero, Martina Di Luca, Enrico Busato, Sami Kilzie, Andrea Dell'Acqua, Giovanna Scarfone, Paolo Vercellini, Marco Petrillo, Giampiero Capobianco, Andrea Ciavattini, Liliana Mereu, Paolo Scollo, Flavia Sorbi, Massimiliano Fambrini, Federico Romano, Giuseppe Ricci, Giuseppe Trojano, Gianluca Raffaello Damiani, Roberto Consonni, Nadia Di Lorenzo, Antonio Lippolis, Raffaele Tinelli, Lorenzo Aguzzoli, Vincenzo D. Mandato, Stefano Palomba, Marcello Tripodi, Davide Calandra, Franco Pellegrini, Fulvio Zullo, Daniela Surico, Valentino Remorgida, Francesco Ruscitto, Paolo Beretta, Enrico Vizza, Ludovico Muzii, Pierluigi Benedetti Panici, Francesco Raspagliesi Gynecologic Oncology, 2022
Development of a Nomogram Predicting the Risk of Persistence/Recurrence of Cervical Dysplasia Giorgio Bogani, Luca Lalli, Francesco Sopracordevole, Andrea Ciavattini, Alessandro Ghelardi, Tommaso Simoncini, Francesco Plotti, Jvan Casarin, Maurizio Serati, Ciro Pinelli, Alice Bergamini, Barbara Gardella, Andrea Dell’Acqua, Ermelinda Monti, Paolo Vercellini, Innocenza Palaia, Giorgia Perniola, Margherita Fischetti, Giusi Santangelo, Alice Fracassi, Giovanni D’Ippolito, Lorenzo Aguzzoli, Vincenzo Dario Mandato, Luca Giannella, Cono Scaffa, Francesca Falcone, Chiara Borghi, Mario Malzoni, Andrea Giannini, Maria Giovanna Salerno, Viola Liberale, Biagio Contino, Cristina Donfrancesco, Michele Desiato, Anna Myriam Perrone, Giulia Dondi, Pierandrea De Iaco, Simone Ferrero, Giuseppe Sarpietro, Maria G. Matarazzo, Antonio Cianci, Stefano Cianci, Sara Bosio, Simona Ruisi, Lavinia Mosca, Raffaele Tinelli, Rosa De Vincenzo, Gian Franco Zannoni, Gabriella Ferrandina, Marco Petrillo, Giampiero Capobianco, Salvatore Dessiole, Annunziata Carlea, Fulvio Zullo, Barbara Muschiato, Stefano Palomba, Stefano Greggi, Arsenio Spinillo, Fabio Ghezzi, Nicola Colacurci, Roberto Angioli, Pierluigi Benedetti Panici, Ludovico Muzii, Giovanni Scambia, Francesco Raspagliesi, Violante Di Donato Vaccines, 2022
Thyroid Function in Pregnancy Alessandro Delitala, Margherita Maioli, Francesco Dessole, Marco Petrillo, Giampiero Capobianco Thyroid Diseases in Pregnancy, 2022
Characteristics and patterns of care of endometrial cancer before and during COVID-19 pandemic Giorgio Bogani, Giovanni Scambia, Chiara Cimmino, Francesco Fanfani, Barbara Costantini, Matteo Loverro, Gabriella Ferrandina, Fabio Landoni, Luca Bazzurini, Tommaso Grassi, Domenico Vitobello, Gabriele Siesto, Anna Myriam Perrone, Vanna Zanagnolo, Pierandrea De Iaco, Francesco Multinu, Fabio Ghezzi, Jvan Casarin, Roberto Berretta, Vito A Capozzi, Errico Zupi, Gabriele Centini, Antonio Pellegrino, Silvia Corso, Guido Stevenazzi, Serena Montoli, Anna Chiara Boschi, Giuseppe Comerci, Pantaleo Greco, Ruby Martinello, Francesco Sopracordevole, Giorgio Giorda, Tommaso Simoncini, Marta Caretto, Enrico Sartori, Federico Ferrari, Antonio Cianci, Giuseppe Sarpietro, Maria Grazia Matarazzo, Fulvio Zullo, Giuseppe Bifulco, Michele Morelli, Annamaria Ferrero, Nicoletta Biglia, Fabio Barra, Simone Ferrero, Umberto Leone Roberti Maggiore, Stefano Cianci, Vito Chiantera, Alfredo Ercoli, Giulio Sozzi, Angela Martoccia, Sergio Schettini, Teresa Orlando, Francesco G Cannone, Giuseppe Ettore, Andrea Puppo, Martina Borghese, Canio Martinelli, Ludovico Muzii, Violante Di Donato, Lorenza Driul, Stefano Restaino, Alice Bergamini, Giorgio Candotti, Luca Bocciolone, Francesco Plotti, Roberto Angioli, Giulia Mantovani, Marcello Ceccaroni, Chiara Cassani, Mattia Dominoni, Laura Giambanco, Silvia Amodeo, Livio Leo, Raphael Thomasset, Diego Raimondo, Renato Seracchioli, Mario Malzoni, Franco Gorlero, Martina Di Luca, Enrico Busato, Sami Kilzie, Andrea Dell'Acqua, Giovanna Scarfone, Paolo Vercellini, Marco Petrillo, Salvatore Dessole, Giampiero Capobianco, Andrea Ciavattini, Giovanni Delli Carpini, Luca Giannella, Liliana Mereu, Saverio Tateo, Flavia Sorbi, Massimiliano Fambrini, Stefania Cicogna, Federico Romano, Giuseppe Ricci, Giuseppe Trojano, Roberto Consonni, Simona Cantaluppi, Antonio Lippolis, Raffaele Tinelli, Giovanni D'Ippolito, Lorenzo Aguzzoli, Vincenzo D Mandato, Stefano Palomba, Davide Calandra, Maurizio Rosati, Cinzia Gallo, Daniela Surico, Valentino Remorgida, Francesco Ruscitto, Paolo Beretta, Pierluigi Benedetti Panici, Francesco Raspagliesi Journal of Gynecologic Oncology, 2022
High-risk HPV-positive and -negative high-grade cervical dysplasia: Analysis of 5-year outcomes Giorgio Bogani, Francesco Sopracordevole, Violante Di Donato, Andrea Ciavattini, Alessandro Ghelardi, Salvatore Lopez, Tommaso Simoncini, Francesco Plotti, Jvan Casarin, Maurizio Serati, Ciro Pinelli, Gaetano Valenti, Alice Bergamini, Barbara Gardella, Andrea Dell'acqua, Ermelinda Monti, Paolo Vercellini, Margherita Fischetti, Giovanni D'ippolito, Lorenzo Aguzzoli, Vincenzo D. Mandato, Paola Carunchio, Gabriele Carlinfante, Luca Giannella, Cono Scaffa, Francesca Falcone, Chiara Borghi, Antonino Ditto, Mario Malzoni, Andrea Giannini, Maria Giovanna Salerno, Viola Liberale, Biagio Contino, Cristina Donfrancesco, Michele Desiato, Anna Myriam Perrone, Giulia Dondi, Pierandrea De Iaco, Valentina Chiappa, Simone Ferrero, Giuseppe Sarpietro, Maria G. Matarazzo, Antonio Cianci, Sara Bosio, Simona Ruisi, Rocco Guerrisi, Claudia Brusadelli, Lavinia Mosca, Antonio Simone Lagana’, Raffaele Tinelli, Mauro Signorelli, Rosa De Vincenzo, Gian Franco Zannoni, Gabriella Ferrandina, Sara Lovati, Marco Petrillo, Salvatore Dessole, Annunziata Carlea, Fulvio Zullo, Roberto Angioli, Stefano Greggi, Arsenio Spinillo, Fabio Ghezzi, Nicola Colacurci, Ludovico Muzii, Pierluigi Benedetti Panici, Giovanni Scambia, Francesco Raspagliesi Gynecologic Oncology, 2021
Recurrence rate after loop electrosurgical excision procedure (LEEP) and laser Conization: A 5-year follow-up study Giorgio BOGANI, Violante DI DONATO, Francesco SOPRACORDEVOLE, Andrea CIAVATTINI, Alessandro GHELARDI, Salvatore LOPEZ, Tommaso SIMONCINI, Francesco PLOTTI, Jvan CASARIN, Maurizio SERATI, Ciro PINELLI, Gaetano VALENTI, Alice BERGAMINI, Barbara GARDELLA, Andrea DELL'ACQUA, Ermelinda MONTI, Paolo VERCELLINI, Margherita FISCHETTI, Giovanni D'IPPOLITO, Lorenzo AGUZZOLI, Vincenzo D. MANDATO, Paola CARUNCHIO, Gabriele CARLINFANTE, Luca GIANNELLA, Cono SCAFFA, Francesca FALCONE, Chiara BORGHI, Antonino DITTO, Mario MALZONI, Andrea GIANNINI, Maria Giovanna SALERNO, Viola LIBERALE, Biagio CONTINO, Cristina DONFRANCESCO, Michele DESIATO, Anna Myriam PERRONE, Giulia DONDI, Pierandrea De IACO, Umberto LEONE ROBERTI MAGGIORE, Mauro SIGNORELLI, Valentina CHIAPPA, Simone FERRERO, Giuseppe SARPIETRO, Maria G. MATARAZZO, Antonio CIANCI, Sara BOSIO, Simona RUISI, Rocco GUERRISI, Claudia BRUSADELLI, Lavinia MOSCA, Raffaele TINELLI, Rosa DE VINCENZO, Gian Franco ZANNONI, Gabriella FERRANDINA, Marco PETRILLO, Salvatore DESSOLE, Roberto ANGIOLI, Stefano GREGGI, Arsenio SPINILLO, Fabio GHEZZI, Nicola COLACURCI, Ludovico MUZII, Pierluigi BENEDETTI PANICI, Giovanni SCAMBIA, Francesco RASPAGLIESI Gynecologic Oncology, 2020
Assessing the long-term role of vaccination against hpv after loop electrosurgical excision procedure (Leep): A propensity-score matched comparison Giorgio Bogani, Francesco Raspagliesi, Francesco Sopracordevole, Andrea Ciavattini, Alessandro Ghelardi, Tommaso Simoncini, Marco Petrillo, Francesco Plotti, Salvatore Lopez, Jvan Casarin, Maurizio Serati, Ciro Pinelli, Gaetano Valenti, Alice Bergamini, Barbara Giannella, Andrea Dell’Acqua, Ermelinda Monti, Paolo Vercellini, Giovanni D’ippolito, Lorenzo Aguzzoli, Vincenzo D Mandato, Paola Carunchio, Gabriele Carlifante, Luca Giannella, Cono Scaffa, Francesca Falcone, Stefano Ferla, Chiara Borghi, Antonino Ditto, Mario Malzoni, Andrea Giannini, Maria Giovanna Salerno, Viola Liberale, Biagio Contino, Cristina Donfrancesco, Michele Desiato, Anna Myriam Perrone, Giulia Dondi, Pierandrea De Iaco, Umberto Leone Roberti Maggiore, Mauro Signorelli, Valentina Chiappa, Simone Ferrero, Giuseppe Sarpietro, Maria G Matarazzo, Antonio Cianci, Sara Bocio, Simona Ruisi, Rocco Guerrisi, Claudia Brusadelli, Lavinia Mosca, Raffaele Tinelli, Rosa De Vincenzo, Gian Franco Zannoni, Gabriella Ferrandina, Salvatore Dessole, Roberto Angioli, Stefano Greggi, Arsenio Spinillo, Fabio Ghezzi, Nicola Colacurci, Margherita Fischetti, Annunziata Carlea, Fulvio Zullo, Ludovico Muzii, Giovanni Scambia, Pierluigi Benedetti Panici, Violante Di Donato Vaccines, 2020
Role of extracellular vesicles in epithelial ovarian cancer: A systematic review Alessandro Lucidi, Danilo Buca, Carlo Ronsini, Sara Tinari, Giuseppina Bologna, Davide Buca, Martina Leombroni, Marco Liberati, Francesco D’Antonio, Giovanni Scambia, Paola Lanuti, Marco Petrillo International Journal of Molecular Sciences, 2020
Materno-fetal and neonatal complications of diabetes in pregnancy: A retrospective study Giampiero Capobianco, Alessandra Gulotta, Giulio Tupponi, Francesco Dessole, Maddalena Pola, Giuseppe Virdis, Marco Petrillo, Valerio Mais, Giorgio Olzai, Roberto Antonucci, Laura Saderi, Pier Luigi Cherchi, Salvatore Dessole, Giovanni Sotgiu Journal of Clinical Medicine, 2020
A combined ANXA2-NDRG1-STAT1 gene signature predicts response to chemoradiotherapy in cervical cancer Marianna Buttarelli, Gabriele Babini, Giuseppina Raspaglio, Flavia Filippetti, Alessandra Battaglia, Alessandra Ciucci, Gabriella Ferrandina, Marco Petrillo, Carmela Marino, Mariateresa Mancuso, Anna Saran, Maria Elena Villani, Angiola Desiderio, Chiara D’Ambrosio, Andrea Scaloni, Giovanni Scambia, Daniela Gallo Journal of Experimental and Clinical Cancer Research, 2019
Patterns of Lymph Node Metastases in Apparent Stage I Low-Grade Epithelial Ovarian Cancer: A Multicenter Study Lucas Minig, Florian Heitz, David Cibula, Jamie N. Bakkum-Gamez, Anna Germanova, Sean C. Dowdy, Eleftheria Kalogera, Ignacio Zapardiel, Kristina Lindemann, Philipp Harter, Giovanni Scambia, Marco Petrillo, Cristina Zorrero, Vanna Zanagnolo, José Miguel Cárdenas Rebollo, Andreas du Bois, Christina Fotopoulou Annals of Surgical Oncology, 2017
Role of CTGF in Sensitivity to Hyperthermia in Ovarian and Uterine Cancers Hiroto Hatakeyama, Sherry Y. Wu, Yasmin A. Lyons, Sunila Pradeep, Wanqin Wang, Qian Huang, Karem A. Court, Tao Liu, Song Nie, Cristian Rodriguez-Aguayo, Fangrong Shen, Yan Huang, Takeshi Hisamatsu, Takashi Mitamura, Nicholas Jennings, Jeajun Shim, Piotr L. Dorniak, Lingegowda S. Mangala, Marco Petrillo, Vladislav A. Petyuk, Athena A. Schepmoes, Anil K. Shukla, Madeline Torres-Lugo, Ju-Seog Lee, Karin D. Rodland, Anna Fagotti, Gabriel Lopez-Berestein, Chun Li, Anil K. Sood Cell Reports, 2016
Nek6 and Hif-1α cooperate with the cytoskeletal gateway of drug resistance to drive outcome in serous ovarian cancer American Journal of Cancer Research, 2015
CD133 antigen expression in ovarian cancer Gabriella Ferrandina, Enrica Martinelli, Marco Petrillo, Maria Grazia Prisco, Gianfranco Zannoni, Stefano Sioletic, Giovanni Scambia BMC Cancer, 2009
Targeting CD133 antigen in cancer Gabriella Ferrandina, Marco Petrillo, Giuseppina Bonanno, Giovanni Scambia Expert Opinion on Therapeutic Targets, 2009
